OHRP - OHR Pharmaceutical, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 58.23M
Enterprise Value 35.93M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.91
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.75

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-18.45%
Return on Equity (ttm)-67.07%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -3.39M
Net Income Avi to Common (ttm)-8.94M
Diluted EPS (ttm)-3.1640
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.13M
Total Cash Per Share (mrq)0.75
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.73
Book Value Per Share (mrq)3.18

Cash Flow Statement

Operating Cash Flow (ttm)-3.32M
Levered Free Cash Flow (ttm)-1.17M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.86
52-Week Change 3-26.90%
S&P500 52-Week Change 34.96%
52 Week High 36.6000
52 Week Low 31.6000
50-Day Moving Average 32.5191
200-Day Moving Average 32.5979

Share Statistics

Avg Vol (3 month) 3184.89k
Avg Vol (10 day) 353.24k
Shares Outstanding 52.83M
Float 2.45M
% Held by Insiders 18.89%
% Held by Institutions 112.72%
Shares Short (Apr 30, 2019) 4214.7k
Short Ratio (Apr 30, 2019) 43.35
Short % of Float (Apr 30, 2019) 48.35%
Short % of Shares Outstanding (Apr 30, 2019) 47.59%
Shares Short (prior month Mar 29, 2019) 4206.34k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 220/1
Last Split Date 3Feb 4, 2019